sodium phenylbutyrate

sodium phenylbutyrate (AMMONAPS) is an FDA-listed pharmaceutical active ingredient. Associated with Amylyx Pharmaceuticals EMEA B.V.. Route of administration: oral. Current US regulatory status: approved.

AMMONAPS is a marketed brand name for sodium phenylbutyrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

sodium phenylbutyrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.